Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2017-06-26 2017-06-26
Drug Identification Number 02453258 02453258
Brand name S.O.S. NALOXONE HYDROCHLORIDE INJECTION S.O.S. NALOXONE HYDROCHLORIDE INJECTION
Common or Proper name NALOXONE NALOXONE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 X 1ML AMPOULES 10 X 1ML AMPOULES
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-04-07 2017-04-07
Actual start date
Estimated end date 2017-06-16 2017-06-16
Actual end date 2017-05-01 2017-05-01
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments